JSM · As filed with the SEC
Navient cash flow statement, by fiscal year
The statement as Navient presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Statements of Cash Flows · USD
| USD | FY2025 Year ended Dec 31, 2025 | FY2024 Year ended Dec 31, 2024 | FY2023 Year ended Dec 31, 2023 | FY2022 Year ended Dec 31, 2022 | FY2021 Year ended Dec 31, 2021 | FY2020 Year ended Dec 31, 2020 | FY2019 Year ended Dec 31, 2019 | FY2018 Year ended Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||
| Net income (loss) | (80,000,000) | 131,000,000 | 228,000,000 | 645,000,000 | 717,000,000 | 412,000,000 | 597,000,000 | 395,000,000 |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||||||||
| Gains on sale of education loans | — | — | 0 | — | (78,000,000) | — | (16,000,000) | — |
| (Gain) on sale of subsidiaries, net | 0 | (191,000,000) | — | — | — | — | — | — |
| Losses on debt repurchases | 0 | 0 | 8,000,000 | — | 73,000,000 | 6,000,000 | (45,000,000) | (19,000,000) |
| Goodwill and acquired intangible asset impairment and amortization expense | 3,000,000 | 146,000,000 | 10,000,000 | 19,000,000 | 30,000,000 | 22,000,000 | 30,000,000 | 47,000,000 |
| Stock-based compensation expense | 21,000,000 | 23,000,000 | 24,000,000 | 19,000,000 | 22,000,000 | 18,000,000 | 25,000,000 | 25,000,000 |
| Mark-to-market (gains)/losses on derivative and hedging activities, net | 124,000,000 | 25,000,000 | 147,000,000 | (590,000,000) | (433,000,000) | 340,000,000 | 130,000,000 | 37,000,000 |
| Provisions for loan losses | — | — | — | — | — | — | 258,000,000 | 370,000,000 |
| Provisions for loan losses | 280,000,000 | 113,000,000 | 123,000,000 | 79,000,000 | (61,000,000) | 155,000,000 | — | — |
| (Increase) decrease in accrued interest receivable | 76,000,000 | 348,000,000 | (50,000,000) | (147,000,000) | 47,000,000 | 22,000,000 | 78,000,000 | (125,000,000) |
| Increase (decrease) in accrued interest payable | (3,000,000) | (31,000,000) | 29,000,000 | 159,000,000 | (55,000,000) | (113,000,000) | (96,000,000) | 58,000,000 |
| Decrease in other assets | — | — | — | — | — | — | — | 321,000,000 |
| Decrease in other assets | 58,000,000 | 91,000,000 | 52,000,000 | 387,000,000 | 145,000,000 | 177,000,000 | 191,000,000 | — |
| Increase (decrease) in other liabilities | (38,000,000) | (196,000,000) | 105,000,000 | (266,000,000) | 295,000,000 | (52,000,000) | (133,000,000) | 31,000,000 |
| Total adjustments | 521,000,000 | 328,000,000 | 448,000,000 | (340,000,000) | (15,000,000) | 575,000,000 | 422,000,000 | — |
| Total net cash provided by operating activities | 441,000,000 | 459,000,000 | 676,000,000 | 305,000,000 | 702,000,000 | 987,000,000 | 1,019,000,000 | 1,140,000,000 |
| Investing activities | ||||||||
| Education loans originated and acquired | (2,482,000,000) | (1,387,000,000) | (970,000,000) | (2,051,000,000) | (6,104,000,000) | (4,641,000,000) | (5,411,000,000) | (3,652,000,000) |
| Principal payments on education loans | 5,182,000,000 | 9,500,000,000 | 8,322,000,000 | 12,540,000,000 | 11,137,000,000 | 11,179,000,000 | 12,472,000,000 | 13,973,000,000 |
| Proceeds from sales of education loans | — | — | 0 | — | 1,588,000,000 | — | 408,000,000 | — |
| Other investing activities, net | (13,000,000) | (6,000,000) | 5,000,000 | 96,000,000 | 68,000,000 | (90,000,000) | 9,000,000 | (76,000,000) |
| Proceeds from sales and maturities of other securities | — | — | — | — | — | — | 7,000,000 | 115,000,000 |
| Purchase of subsidiary, net of cash acquired | — | — | 0 | — | (16,000,000) | — | — | — |
| Disposal of a subsidiaries, net of cash disposed of | 25,000,000 | 359,000,000 | — | — | — | — | — | — |
| Total net cash provided by investing activities | 2,712,000,000 | 8,466,000,000 | 7,357,000,000 | 10,585,000,000 | 6,673,000,000 | 6,448,000,000 | 7,485,000,000 | 10,360,000,000 |
| Financing activities | ||||||||
| Borrowings collateralized by loans in trust - issued | 2,162,000,000 | 1,106,000,000 | 1,357,000,000 | 2,243,000,000 | 7,973,000,000 | 7,959,000,000 | 7,919,000,000 | 9,006,000,000 |
| Borrowings collateralized by loans in trust - repaid | (5,345,000,000) | (9,770,000,000) | (9,753,000,000) | (12,581,000,000) | (11,163,000,000) | (11,858,000,000) | (14,271,000,000) | (14,057,000,000) |
| Asset-backed Securities, Securitized Loans and Receivables | 176,000,000 | (116,000,000) | 8,000,000 | 1,094,000,000 | (2,169,000,000) | (1,915,000,000) | (907,000,000) | (2,833,000,000) |
| Long-term notes issued | — | — | — | — | — | — | — | 495,000,000 |
| Long-term notes repaid | — | — | — | — | — | — | (1,950,000,000) | (2,947,000,000) |
| Long-term unsecured notes issued | 495,000,000 | 0 | 989,000,000 | — | 1,237,000,000 | 682,000,000 | — | — |
| Long-term unsecured notes repaid | (554,000,000) | (507,000,000) | (2,159,000,000) | (15,000,000) | (2,702,000,000) | (1,832,000,000) | — | — |
| Other financing activities, net | 88,000,000 | (79,000,000) | (101,000,000) | 89,000,000 | 197,000,000 | (192,000,000) | (189,000,000) | (162,000,000) |
| Common stock repurchased | (111,000,000) | (179,000,000) | (310,000,000) | (400,000,000) | (600,000,000) | (400,000,000) | (440,000,000) | (220,000,000) |
| Common dividends paid | (63,000,000) | (70,000,000) | (78,000,000) | (91,000,000) | (107,000,000) | (123,000,000) | (147,000,000) | (166,000,000) |
| Total net cash used in financing activities | (3,152,000,000) | (9,615,000,000) | (10,047,000,000) | (9,661,000,000) | (7,334,000,000) | (7,679,000,000) | (9,985,000,000) | (10,884,000,000) |
| Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents | 1,000,000 | (690,000,000) | (2,014,000,000) | 1,229,000,000 | 41,000,000 | (244,000,000) | (1,481,000,000) | 616,000,000 |
| Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period | 2,103,000,000 | 2,793,000,000 | 4,807,000,000 | 3,578,000,000 | 3,537,000,000 | 3,781,000,000 | 5,262,000,000 | 4,646,000,000 |
| Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period | 2,104,000,000 | 2,103,000,000 | 2,793,000,000 | 4,807,000,000 | 3,578,000,000 | 3,537,000,000 | 3,781,000,000 | 5,262,000,000 |
| Supplemental disclosure of cash flow information: | ||||||||
| Interest | 2,563,000,000 | 3,238,000,000 | 3,431,000,000 | 1,904,000,000 | 1,378,000,000 | 2,059,000,000 | 3,479,000,000 | 3,460,000,000 |
| Income taxes paid | — | 38,000,000 | 57,000,000 | 30,000,000 | 190,000,000 | 74,000,000 | 93,000,000 | 57,000,000 |
| Income taxes paid | 26,000,000 | — | — | — | — | — | — | — |
| Income taxes received | (7,000,000) | (3,000,000) | (5,000,000) | (12,000,000) | (11,000,000) | — | (4,000,000) | (6,000,000) |
| Reconciliation of the Consolidated Statements of Cash Flows to the Consolidated Balance Sheets: | ||||||||
| Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period | — | — | — | — | — | 3,537,000,000 | — | 5,262,000,000 |
| Investing activity - Held-to-maturity asset backed securities retained related to sales of education loans | — | — | 0 | — | 83,000,000 | — | 22,000,000 | — |
| Operating activity - Servicing assets recognized upon sales of education loans | — | — | 0 | — | 21,000,000 | — | 3,000,000 | — |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.